INS and metabolic disease: T2DM is a metabolic disorder—as opposed to Type 1 diabetes, which has a strong autoimmune, inflammatory component (7)—which develops as a result of either insufficient insulin secretion from pancreatic β cells, or insulin resistance in insulin-sensitive tissues such as liver, adipose tissue, and skeletal muscle (8–10).